3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
3
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Lung Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Glioblastoma
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Glioma
2
Endometrial Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma
1
Rhabdoid Tumor
1
Renal Insufficiency
1
Recurrence
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Postoperative Complications
1
Pancreatic carcinoma, familial
1
Interventions
Carboplatin
12
pembrolizumab
8
Paclitaxel
8
Cyclophosphamide
8
toripalimab
4
sacituzumab govitecan
4
olaparib
4
Epirubicin
4
Drug Therapy
4
Doxorubicin
4
eribulin
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
Specimen Handling
2
Radiotherapy
2
Injections
2
Immune Checkpoint Inhibitors
2
Gemcitabine
2
Biopsy
2
tislelizumab
1
taxane
1
poly ICLC
1
pirfenidone
1
palbociclib
1
ivarmacitinib
1
inavolisib
1
fludarabine
1
daratumumab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Triple Negative Breast Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT07570524
2026-05-06
PRIME-TNBC
Center Eugene Marquis
Not yet recruiting
200 enrolled